The real mechanism of VPA-induced hyperammonemia remains unknown
Authors:
- 3 December 2010
- journal article
- case report
- Published by Elsevier in General Hospital Psychiatry
- Vol. 33 (1) , 84.e3-84.e4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: Relationship to blood carnitine statusEpilepsy Research, 2009
- Clinical alertness to valproic acid-induced hyperammonemia-two case reportsJournal of Psychopharmacology, 2009
- Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric settingInternational Clinical Psychopharmacology, 2007
- Hyperammonemia Due to Valproic Acid in the Psychiatric SettingAmerican Journal of Psychiatry, 2007
- Simultaneous side effects of both clozapine and valproateIntensive Care Medicine, 2001
- The Role of Carnitine Supplementation during Valproic Acid TherapyAnnals of Pharmacotherapy, 2000
- Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugsInternational Journal of Clinical and Laboratory Research, 1999
- Muscle carnitine deficiency in patients using valproic acidThe Journal of Pediatrics, 1991